𩺠å
§ç§å°ç§èåç
ð äžé éé»
- 22E 匷調ïŒpost-COVID olfactory dysfunction
- AD/PD prodromal hyposmia èªå¯
- Olfactory training evidence-based
ð§ é²éæ©èœ
- Olfactory neurons regenerateïŒå°æžèœåçç¥ç¶å
ä¹äžïŒ
- COVID æ©èœïŒnon-neural sustentacular cell ACE2 expression â inflammation
- AD/PDïŒÎ±-synuclein/tau æ©æ affect olfactory bulb
ð æ²»ç
- Olfactory training 12-24 é±
- Topical steroid for rhinosinusitis
- Surgery for polyp
- Watch for AD/PD if persistent + progressive
ð å°ç£ Context
- COVID æ anosmia clinic emerging
- å
芺èšç·Žå
å¥ä¿æ¢ä»¶
- ENT é蚺垞被諮詢
ð å
§å°éé»
- å
芺 / å³èŠº ç¥ç¶
- Conductive vs sensorineural
- Post-COVID
- AD/PD prodromal
è·šç« ç¯
â ïž AI èçš¿ã